Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosome Disorders | 9 | 2024 | 312 | 1.580 |
Why?
|
| Autism Spectrum Disorder | 7 | 2022 | 430 | 1.500 |
Why?
|
| ras GTPase-Activating Proteins | 5 | 2020 | 19 | 1.380 |
Why?
|
| Chromosome Deletion | 10 | 2024 | 657 | 1.290 |
Why?
|
| Nerve Tissue Proteins | 10 | 2024 | 1130 | 1.280 |
Why?
|
| Epilepsy | 5 | 2021 | 891 | 1.250 |
Why?
|
| Brain Waves | 2 | 2019 | 47 | 1.090 |
Why?
|
| Intellectual Disability | 7 | 2022 | 1093 | 1.020 |
Why?
|
| Autistic Disorder | 4 | 2022 | 387 | 0.860 |
Why?
|
| Seizures | 6 | 2024 | 895 | 0.790 |
Why?
|
| Chromosomes, Human, Pair 22 | 7 | 2024 | 102 | 0.720 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 147 | 0.600 |
Why?
|
| Mutation | 7 | 2020 | 6238 | 0.580 |
Why?
|
| Neurodevelopmental Disorders | 4 | 2021 | 551 | 0.580 |
Why?
|
| Anticonvulsants | 3 | 2024 | 389 | 0.580 |
Why?
|
| Neurogenesis | 1 | 2020 | 220 | 0.560 |
Why?
|
| Neurofibromatosis 2 | 1 | 2017 | 10 | 0.550 |
Why?
|
| Child Development | 1 | 2019 | 288 | 0.510 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 481 | 0.490 |
Why?
|
| Growth and Development | 1 | 2015 | 23 | 0.470 |
Why?
|
| Haploinsufficiency | 7 | 2021 | 270 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2015 | 111 | 0.450 |
Why?
|
| Sulfite Oxidase | 1 | 2014 | 4 | 0.440 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2009 | 381 | 0.440 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2014 | 30 | 0.440 |
Why?
|
| Stiff-Person Syndrome | 1 | 2014 | 5 | 0.440 |
Why?
|
| Genetic Loci | 1 | 2015 | 362 | 0.410 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2014 | 112 | 0.400 |
Why?
|
| Disease Progression | 1 | 2019 | 2225 | 0.390 |
Why?
|
| Spasms, Infantile | 1 | 2014 | 175 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2012 | 98 | 0.360 |
Why?
|
| Isoxazoles | 1 | 2011 | 24 | 0.360 |
Why?
|
| Repressor Proteins | 4 | 2006 | 813 | 0.350 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1048 | 0.340 |
Why?
|
| Electroencephalography | 5 | 2019 | 906 | 0.330 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 369 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2021 | 150 | 0.320 |
Why?
|
| Abnormalities, Multiple | 2 | 2014 | 982 | 0.320 |
Why?
|
| Humans | 39 | 2024 | 132202 | 0.300 |
Why?
|
| Mutation, Missense | 3 | 2024 | 934 | 0.290 |
Why?
|
| Child, Preschool | 12 | 2024 | 14841 | 0.290 |
Why?
|
| Brain | 4 | 2019 | 3190 | 0.290 |
Why?
|
| Sleep | 2 | 2019 | 370 | 0.280 |
Why?
|
| Child | 13 | 2024 | 25789 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2014 | 142 | 0.250 |
Why?
|
| Nerve Net | 2 | 2020 | 264 | 0.250 |
Why?
|
| Adolescent | 12 | 2024 | 20520 | 0.250 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1501 | 0.250 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2015 | 775 | 0.240 |
Why?
|
| Developmental Disabilities | 3 | 2024 | 748 | 0.240 |
Why?
|
| Male | 21 | 2024 | 65011 | 0.230 |
Why?
|
| Phenotype | 7 | 2023 | 4540 | 0.230 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 604 | 0.230 |
Why?
|
| Catatonia | 1 | 2024 | 17 | 0.220 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 285 | 0.220 |
Why?
|
| Homeostasis | 2 | 2009 | 730 | 0.210 |
Why?
|
| Quality of Life | 3 | 2022 | 2150 | 0.210 |
Why?
|
| Female | 22 | 2024 | 70742 | 0.210 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2015 | 578 | 0.210 |
Why?
|
| Caregivers | 3 | 2022 | 597 | 0.200 |
Why?
|
| Point Mutation | 2 | 2018 | 350 | 0.200 |
Why?
|
| Dietary Fats | 1 | 2004 | 296 | 0.190 |
Why?
|
| Mice | 12 | 2023 | 18559 | 0.190 |
Why?
|
| Feeding Behavior | 2 | 2006 | 728 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 3357 | 0.180 |
Why?
|
| Protein Stability | 2 | 2019 | 167 | 0.180 |
Why?
|
| Animals | 14 | 2023 | 34947 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2023 | 2443 | 0.180 |
Why?
|
| Young Adult | 7 | 2024 | 9935 | 0.170 |
Why?
|
| Protein Biosynthesis | 1 | 2023 | 590 | 0.170 |
Why?
|
| Parent-Child Relations | 1 | 2022 | 253 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2022 | 208 | 0.160 |
Why?
|
| Transcription Factors, General | 1 | 2020 | 7 | 0.160 |
Why?
|
| Chromosomes, Human, X | 1 | 2021 | 158 | 0.160 |
Why?
|
| Nervous System | 1 | 2020 | 127 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2019 | 92 | 0.160 |
Why?
|
| Genetic Association Studies | 3 | 2020 | 855 | 0.150 |
Why?
|
| Behavior | 1 | 2019 | 74 | 0.150 |
Why?
|
| Dendrites | 1 | 2020 | 204 | 0.150 |
Why?
|
| ras Proteins | 1 | 2019 | 146 | 0.150 |
Why?
|
| Mental Health | 1 | 2022 | 376 | 0.150 |
Why?
|
| Sensation Disorders | 1 | 2018 | 24 | 0.150 |
Why?
|
| Fetal Development | 1 | 2020 | 134 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2019 | 92 | 0.150 |
Why?
|
| Infant | 7 | 2024 | 13184 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 109 | 0.150 |
Why?
|
| Wolf-Hirschhorn Syndrome | 1 | 2018 | 8 | 0.150 |
Why?
|
| Touch Perception | 1 | 2018 | 21 | 0.150 |
Why?
|
| Touch | 1 | 2018 | 39 | 0.150 |
Why?
|
| Parenting | 1 | 2022 | 349 | 0.140 |
Why?
|
| Somatosensory Cortex | 1 | 2018 | 57 | 0.140 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 106 | 0.140 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2020 | 117 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3852 | 0.140 |
Why?
|
| Muscle Hypotonia | 1 | 2019 | 200 | 0.140 |
Why?
|
| Gene Dosage | 2 | 2013 | 449 | 0.140 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 359 | 0.140 |
Why?
|
| Aggression | 1 | 2019 | 230 | 0.130 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 2449 | 0.130 |
Why?
|
| RNA Interference | 1 | 2019 | 514 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2019 | 254 | 0.130 |
Why?
|
| Synapses | 1 | 2020 | 461 | 0.130 |
Why?
|
| Alleles | 2 | 2020 | 1680 | 0.130 |
Why?
|
| Cell Enlargement | 1 | 2016 | 7 | 0.130 |
Why?
|
| RNA | 1 | 2020 | 548 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2018 | 246 | 0.130 |
Why?
|
| Neurites | 1 | 2016 | 45 | 0.120 |
Why?
|
| Aging | 2 | 2019 | 1257 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2016 | 92 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 1996 | 201 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 461 | 0.120 |
Why?
|
| Infant, Newborn | 4 | 2015 | 8562 | 0.120 |
Why?
|
| Parents | 1 | 2022 | 1076 | 0.120 |
Why?
|
| Behavior, Animal | 2 | 2019 | 507 | 0.120 |
Why?
|
| Physical Examination | 1 | 2016 | 166 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2019 | 2493 | 0.110 |
Why?
|
| Pandemics | 1 | 2022 | 1186 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2020 | 3062 | 0.110 |
Why?
|
| Wakefulness | 2 | 2019 | 105 | 0.110 |
Why?
|
| Genomics | 1 | 2022 | 1645 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2020 | 408 | 0.110 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 11 | 0.110 |
Why?
|
| Genes, Duplicate | 1 | 2013 | 16 | 0.110 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 28 | 0.110 |
Why?
|
| Down Syndrome | 1 | 1996 | 230 | 0.100 |
Why?
|
| Gene Expression | 2 | 2020 | 1563 | 0.100 |
Why?
|
| Hyperkinesis | 1 | 2013 | 27 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 634 | 0.100 |
Why?
|
| Lithium | 1 | 2013 | 71 | 0.100 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 591 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17352 | 0.100 |
Why?
|
| Adult | 8 | 2024 | 31599 | 0.100 |
Why?
|
| Valproic Acid | 1 | 2013 | 163 | 0.100 |
Why?
|
| Obesity | 2 | 2006 | 2406 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1993 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 3975 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1963 | 0.090 |
Why?
|
| Gene Deletion | 3 | 2020 | 795 | 0.090 |
Why?
|
| Calcium Channels, T-Type | 1 | 2011 | 12 | 0.090 |
Why?
|
| Sodium Channel Blockers | 1 | 2011 | 24 | 0.090 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 115 | 0.090 |
Why?
|
| Actins | 1 | 2013 | 338 | 0.090 |
Why?
|
| Pedigree | 2 | 2018 | 1725 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4679 | 0.080 |
Why?
|
| Activity Cycles | 1 | 2009 | 1 | 0.080 |
Why?
|
| Sleep, REM | 1 | 2009 | 23 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3388 | 0.080 |
Why?
|
| Syndrome | 1 | 2012 | 1171 | 0.080 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 45 | 0.080 |
Why?
|
| Electromyography | 1 | 2009 | 140 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2009 | 3873 | 0.070 |
Why?
|
| Pro-Opiomelanocortin | 2 | 2006 | 76 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1597 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 331 | 0.070 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 32 | 0.070 |
Why?
|
| Hyperphagia | 2 | 2006 | 46 | 0.070 |
Why?
|
| Age of Onset | 2 | 2018 | 625 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 316 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2016 | 5146 | 0.060 |
Why?
|
| Anorexia | 1 | 2006 | 22 | 0.060 |
Why?
|
| Base Sequence | 2 | 2022 | 2903 | 0.060 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2006 | 59 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2671 | 0.060 |
Why?
|
| Drosophila | 1 | 2009 | 809 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3779 | 0.050 |
Why?
|
| Body Constitution | 1 | 2004 | 42 | 0.050 |
Why?
|
| Neurons | 3 | 2019 | 2011 | 0.050 |
Why?
|
| Genotype | 3 | 2020 | 2701 | 0.050 |
Why?
|
| Internal Ribosome Entry Sites | 1 | 2023 | 2 | 0.050 |
Why?
|
| Eating | 1 | 2006 | 389 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 28869 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 272 | 0.050 |
Why?
|
| Homologous Recombination | 1 | 2022 | 100 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2006 | 4765 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2023 | 879 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 4724 | 0.040 |
Why?
|
| Cell Size | 1 | 2020 | 86 | 0.040 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 30 | 0.040 |
Why?
|
| Sex Factors | 1 | 2004 | 1352 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 79 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 65 | 0.040 |
Why?
|
| Body Weight | 1 | 2004 | 1005 | 0.040 |
Why?
|
| Post-Synaptic Density | 1 | 2019 | 11 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 813 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 377 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2018 | 295 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 527 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 293 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 281 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 368 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2686 | 0.030 |
Why?
|
| alpha-MSH | 2 | 2006 | 17 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 489 | 0.030 |
Why?
|
| Pregnancy | 2 | 2018 | 7561 | 0.030 |
Why?
|
| Memory | 1 | 2019 | 353 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 824 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 759 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 796 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2019 | 1606 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 623 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2000 | 1230 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 698 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 2014 | 140 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2021 | 1132 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 156 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 1292 | 0.030 |
Why?
|
| Cognition | 1 | 2018 | 813 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6539 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1975 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3616 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 1583 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3693 | 0.020 |
Why?
|
| Aged | 1 | 2009 | 21360 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 13012 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7105 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2006 | 28 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2006 | 52 | 0.020 |
Why?
|
| Growth | 1 | 2006 | 102 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 636 | 0.010 |
Why?
|
| Transgenes | 1 | 2006 | 334 | 0.010 |
Why?
|
| Heterozygote | 1 | 2006 | 717 | 0.010 |
Why?
|
| Body Composition | 1 | 2006 | 559 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1718 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2006 | 804 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 1456 | 0.010 |
Why?
|
| Diet | 1 | 2006 | 1173 | 0.010 |
Why?
|